文献速递肾小球疾病遗传性与小管间质肾病

大规模平行测序与靶向外显子组可诊断家族性肾脏病的潜在遗传病因

Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.
PubMed 文献 · Kidney Int · 2017-08-23

本研究报道了一个经国家认证的家族性肾脏病诊断性遗传服务的结果,采用专家多学科团队制定的靶向外显子测序方法(包含10个多基因面板、207个基因),并根据患者表型进行个体化变异评估。在两年内转诊的135个家族中,58个家族发现了致病性遗传变异。儿科与成人先证者家族的诊断率相似(46% vs 40%),但某些面板如非典型溶血性尿毒症综合征存在显著差异(88% vs 17%)。Alport综合征(27例中22例)和小管疾病(10例中8例)诊断率高,而先天性肾脏和尿路畸形的单基因诊断率仅为13例中1例。基于表型的靶向方法发现的意义不明变异较少,表明该方法在大多数肾脏表型中具有显著的诊断能力。

要点

  • Alport综合征和小管疾病诊断率较高,CAKUT诊断率低。
  • 儿科与成人先证者总体诊断率相似,但aHUS面板差异显著。

核心结论

  • 靶向大规模平行测序在家族性肾脏病中可诊断大多数肾脏表型下的潜在遗传病。

研究设计与样本

  • 国家认证的诊断性遗传服务,采用专家多学科团队制定的靶向外显子测序方法(10个多基因面板,207个基因),对135个转诊家族进行变异评估。

主要发现

  • 135个家族中58个发现致病性遗传变异。
  • 儿科与成人先证者家族诊断率分别为46%和40%。
  • 非典型溶血性尿毒症综合征面板儿科诊断率88%,成人17%。
  • Alport综合征诊断率22/27,小管疾病8/10,先天性肾脏和尿路畸形1/13。

关键数值与推荐

  • 采用10个多基因面板共207个基因进行靶向外显子测序。
  • 根据患者表型进行个体化变异评估。

临床怎么用

  • 对于家族性肾脏病,尤其是Alport综合征和小管疾病,可考虑使用靶向多基因面板测序辅助遗传诊断。
  • 基于表型的靶向方法可减少意义不明变异,适合诊断服务。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inherited kidney disease encompasses a broad range of disorders, with both multiple genes contributing to specific phenotypes and single gene defects having multiple clinical presentations. Advances in sequencing capacity may allow a genetic diagnosis for familial renal disease, by testing the increasing number of known causative genes. However, there has been limited translation of research findings of causative genes into clinical settings. Here, we report the results of a national accredited diagnostic genetic service for familial renal disease. An expert multidisciplinary team developed a targeted exomic sequencing approach with ten curated multigene panels (207 genes) and variant assessment individualized to the patient's phenotype. A genetic diagnosis (pathogenic genetic variant[s]) was identified in 58 of 135 families referred in two years. The genetic diagnosis rate was similar between families with a pediatric versus adult proband (46% vs 40%), although significant differences were found in certain panels such as atypical hemolytic uremic syndrome (88% vs 17%). High diagnostic rates were found for Alport syndrome (22 of 27) and tubular disorders (8 of 10), whereas the monogenic diagnostic rate for congenital anomalies of the kidney and urinary tract was one of 13. Quality reporting was aided by a strong clinical renal and genetic multidisciplinary committee review. Importantly, for a diagnostic service, few variants of uncertain significance were found with this targeted, phenotype-based approach. Thus, use of targeted massively parallel sequencing approaches in inherited kidney disease has a significant capacity to diagnose the underlying genetic disorder across most renal phenotypes.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Mallett AJ, McCarthy HJ, Ho G, et al. Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. Kidney Int. 2017. PMID: 28844315. doi:10.1016/j.kint.2017.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。